title: Predictors of quality of life in inpatients with schizophrenia.
abstract: Shortening hospital stays has become a key focus in psychiatric care in recent years. However, patients with schizophrenia account for about 60% of inpatients in psychiatry departments in Japan. This study was designed to investigate the relationship between quality of life (QOL) and key indicators for long-term hospital stays among schizophrenia inpatients. A further aim was to elucidate the clinical determinants of QOL among long-stay inpatients. The study sample consisted of 217 inpatients with schizophrenia. Age, duration of illness, duration of hospitalization, years of education, body mass index, neurocognitive function, drug-induced extrapyramidal symptoms, involuntary movements, psychiatric symptoms, and dose equivalents of antipsychotics and anticholinergic agents were used as index factors. Pearson linear correlation and regression analyses were performed to examine the associations between QOL and the above-mentioned factors. Negative symptoms, psychological discomfort, and resistance as rated on the Brief Psychiatric Rating Scale (BPRS) were correlated with all subscale scores of the Japanese version of the Schizophrenia Quality of Life Scale (JSQLS). Stepwise regression showed that negative symptoms, psychological discomfort, and resistance predicted the dysfunction of psycho-social activity score and the dysfunction of motivation and energy score on the JSQLS. This study shows that active treatment for negative symptoms, psychological discomfort, and resistance should be recommended to improve QOL among inpatients with schizophrenia.
authors.affiliation: Faculty of Health and Welfare, Prefectural University of Hiroshima, Mihara, Japan. fujimaki@pu-hiroshima.ac.jp
authors.forename: Koichiro
authors.initials: K
authors.lastname: Fujimaki
authors.forename: Shigeru
authors.initials: S
authors.lastname: Morinobu
authors.forename: Hidehisa
authors.initials: H
authors.lastname: Yamashita
authors.forename: Terumichi
authors.initials: T
authors.lastname: Takahashi
authors.forename: Shigeto
authors.initials: S
authors.lastname: Yamawaki
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015992:Body Mass Index; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003072:Cognition Disorders / Q000150:complications; D004409:Dyskinesia, Drug-Induced / Q000523:psychology; D004522:Educational Status; D005260:Female; D006801:Humans; D007297:Inpatients / Q000523:psychology; D007564:Japan; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011788:Quality of Life / Q000523:psychology*; D012559:Schizophrenia / Q000188:drug therapy; D012565:Schizophrenic Psychology; D013223:Statistics as Topic / Q000379:methods
chemical_list: D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists